PAOG Publishes 2022 Strategic Update
January 28, 2022 16:57 ET
|
PAO Group, Inc.
Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy....
PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development
January 25, 2022 10:15 ET
|
PAO Group, Inc.
Sandusky, OH, Jan. 25, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today cited recently published information on research indicating CBDA and CBGA, compounds found in hemp, “block a...
PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA
January 06, 2022 09:19 ET
|
PAO Group, Inc.
Sandusky, OH, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) is...
UPDATE -- PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
December 15, 2021 13:20 ET
|
PAO Group, Inc.
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full spectrum CBD products are now available for sale at...
PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
December 15, 2021 11:22 ET
|
PAO Group, Inc.
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full spectrum CBD products are now available for sale at...
PAOG New Pharmaceutical Product Developments Could Generate Rapid Revenue Surge
November 17, 2021 10:10 ET
|
PAO Group, Inc.
Sandusky, OH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its...
PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To 2021 Revenue Potential
November 09, 2021 13:03 ET
|
PAO Group, Inc.
Sandusky, OH, Nov. 09, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by year end. PAOG...
PAOG Adds Bioidentical Synthetic CBD To Research Pipeline
November 08, 2021 11:42 ET
|
PAO Group, Inc.
Sandusky, OH, Nov. 08, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG...
PAOG Entertains Partnership To Accelerate Development Of CBD Pharmaceutical Treatment For $14 Billion COPD Market
October 28, 2021 12:01 ET
|
PAO Group, Inc.
Sandusky, OH, Oct. 28, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is entertaining a partnership opportunity to accelerate the ongoing development of its...
PAOG Targets First Acquisition By Year End To Accelerate 2022 Revenue Growth
October 26, 2021 10:46 ET
|
PAO Group, Inc.
Sandusky, OH, Oct. 26, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s merger and acquisition development pipeline supports plans for a first acquisition to...